Wuhan Wuyao Pharmaceutical Co., Ltd
  • Home
  • About Wuyao
    Introduction to Wuyao
    Organizational Structure
    Enterprise honor
    Enterprise culture
    Development process
    Product display
    Complaint reporting
  • About Yangxin
    Company Introduction
    Intermediates/Fine Chemicals
    Food Additives
    API
  • News
    Company News
    Industry News
    Media coverage
  • Network
    Business Layout
    Domestic customers
    Foreign customers
  • Contact Us
    Contact Information
    Online message
中文版
  • Home
  • About Wuyao
    Introduction to Wuyao
    Organizational Structure
    Enterprise honor
    Enterprise culture
    Development process
    Product display
    Complaint reporting
  • About Yangxin
    Company Introduction
    Intermediates/Fine Chemicals
    Food Additives
    API
  • News
    Company News
    Industry News
    Media coverage
  • Network
    Business Layout
    Domestic customers
    Foreign customers
  • Contact Us
    Contact Information
    Online message
  • Language
    中文版
News dynamics

News dynamics

  • Home page
全部分类
  • Company News

  • Industry News

  • Media coverage

Announcement on Contact Information of Procurement Demand for API

Announcement on Contact Information of Procurement Demand for API

2022-01-05

View Details
Waste gas detection 2021.3.31

Waste gas detection 2021.3.31

2021-04-29

View Details
Waste gas detection 2021.3.10

Waste gas detection 2021.3.10

2021-04-29

View Details
Waste gas detection 2021.2.19

Waste gas detection 2021.2.19

2021-04-29

View Details
Information disclosure on hazardous waste generation and disposal in 2020

Information disclosure on hazardous waste generation and disposal in 2020

2021-01-20

View Details
It is estimated that the market size of the domestic stem cell industry will reach 100 billion yuan by 2016.

It is estimated that the market size of the domestic stem cell industry will reach 100 billion yuan by 2016.

Medical Network, August 26-the State Health and Family Planning Commission and the State Food and Drug Administration recently jointly issued China's first "measures for the Administration of Stem Cell Clinical Research", which standardizes the institutional qualifications and conditions of stem cell clinical research. and explicitly prohibit the publication of stem cell clinical research advertisements, limit a number of measures to protect the rights and interests of patients. Data show that it is estimated that by 2016, the market size of the domestic stem cell industry will reach 100 billion yuan. Some people in the industry believe that with the announcement of the management measures, the stem cell industry, especially in the field of treatment, will usher in spring.

2019-09-27

View Details
Food and Drug Administration Launches 2015 National Safe Drug Use Month

Food and Drug Administration Launches 2015 National Safe Drug Use Month

According to the requirements of the "National Food and Drug Safety Science Popularization Action Plan (2011-2015)", the "National Safe Drug Month" (hereinafter referred to as the "Safety Month") is held every September. In order to effectively carry out this year's safety month activities, relevant matters are hereby notified as follows:

2019-09-27

View Details
Wuhan Wuyao Pharmaceutical Co., Ltd. Cleaner Production Audit Information Announcement

Wuhan Wuyao Pharmaceutical Co., Ltd. Cleaner Production Audit Information Announcement

Wuhan Wuyao Pharmaceutical Co., Ltd. Cleaner Production Audit Information Announcement Release Unit: Wuhan Wuyao Pharmaceutical Co., Ltd. First Release Date: November 6, 2017 According to the the People's Republic of China Cleaner Production Promotion Law, Cleaner Production Audit Measures and other relevant documents, the clean production compliance of Wuhan Wuyao Pharmaceutical Co., Ltd. and the basic information, pollutant emission and total amount control of enterprises in 2016 are hereby announced as follows, all sectors of society are requested to supervise the implementation of cleaner production audits by our company. 1. Project Name and Project Summary Project Name: Cleaner Production Audit of Wuhan Wuyao Pharmaceutical Co., Ltd.

2017-11-06

View Details
< 123456 >
  • About Wuyao

    • Introduction to Wuyao

    • Organizational Structure

    • Enterprise honor

    • Enterprise culture

    • Development process

    • Product display

  • About Yangxin

    • Company Introduction

    • Intermediates/Fine Chemicals

    • Food Additives

    • API

  • News

    • Company News

    • Industry News

    • Media coverage

  • Network

    • Business Layout

    • Domestic customers

    • Foreign customers

  • Contact Us

    • Contact Information

    • Online message

Mobile Web
Mobile Web

Copyright: Wuhan Wuyao Pharmaceutical Co., Ltd

· Business license · Cloud information · City Station ·

This website already supports IPV6 access

Power by:300.cnWuhan SEO